112 related articles for article (PubMed ID: 2525479)
1. Early enhanced beta cell replication in normoglycaemic Wistar rats in response to a subdiabetogenic dose of streptozotocin.
Ziegler B; Lucke S; Besch W; Hahn HJ
Exp Clin Endocrinol; 1989 Apr; 93(1):1-10. PubMed ID: 2525479
[TBL] [Abstract][Full Text] [Related]
2. S-methyl-L-thiocitrulline counteracts interleukin 1 beta induced suppression of pancreatic islet function in vitro, but does not protect against multiple low-dose streptozotocin-induced diabetes in vivo.
Sternesjö J; Welsh N; Sandler S
Cytokine; 1997 May; 9(5):352-9. PubMed ID: 9195135
[TBL] [Abstract][Full Text] [Related]
3. Destruction of pancreatic beta cells in rats by complete Freund's adjuvant combined with non-diabetogenic doses of streptozotocin.
Kohnert KD; Odselius R; Fält K; Ziegler B; Ziegler M; Falkmer S
Diabetes Res; 1987 May; 5(1):1-11. PubMed ID: 2957141
[TBL] [Abstract][Full Text] [Related]
4. Genetic control of diabetes induction by complete Freund's adjuvant combined with subdiabetogenic doses of streptozotocin in Lewis rats--evidence for transient cytotoxicity against beta cells.
Ziegler B; Tietz S; Kohnert KD; Köhler E; Knospe S; Klöting I; Ziegler M
Exp Clin Endocrinol; 1987 Aug; 89(3):269-75. PubMed ID: 2959492
[TBL] [Abstract][Full Text] [Related]
5. Insulin therapy does not diminish beta-cell damage in the neonatal streptozotocin-injected rat.
Wolffenbuttel BH; Vreeburg J
Diabetes Res; 1988 Oct; 9(2):77-9. PubMed ID: 3073032
[TBL] [Abstract][Full Text] [Related]
6. Insulin-induced immunohistochemical and morphological changes in pancreatic beta-cells of streptozotocin-treated diabetic rats.
Adewole SO; Ojewole JA
Methods Find Exp Clin Pharmacol; 2007 Sep; 29(7):447-55. PubMed ID: 17982509
[TBL] [Abstract][Full Text] [Related]
7. Sensitivity of BB rat beta cells as determined by dose-responses to the cytotoxic effects of streptozotocin and alloxan.
Yale JF; Grose M; Videtic GM; Marliss EB
Diabetes Res; 1986 Mar; 3(3):161-7. PubMed ID: 2940045
[TBL] [Abstract][Full Text] [Related]
8. Pregnancy-associated changes in the endocrine pancreas of normoglycaemic streptozotocin-treated Wistar rats.
Ziegler B; Lucke S; Besch W; Hahn HJ
Diabetologia; 1985 Mar; 28(3):172-5. PubMed ID: 3888760
[TBL] [Abstract][Full Text] [Related]
9. Biochemical, immunohistochemical and ultrastructural studies of the alteration of pancreatic beta cells resulting from the combined effects of complete Freund's adjuvant and non-diabetogenic doses of streptozotocin.
Kohnert KD; Ziegler B; Fält K; Odselius R; Ziegler M; Falkmer S
Exp Clin Endocrinol; 1987 Aug; 89(3):259-68. PubMed ID: 2959491
[TBL] [Abstract][Full Text] [Related]
10. Glucagon secretion by dispersed alpha cell enriched islets from streptozotocin treated hamsters in perifusion.
Dunbar JC; Brown A
Horm Metab Res; 1984 May; 16(5):221-5. PubMed ID: 6234215
[TBL] [Abstract][Full Text] [Related]
11. Streptozotocin alters pancreatic beta-cell responsiveness to glucose within six hours of injection into rats.
West E; Simon OR; Morrison EY
West Indian Med J; 1996 Jun; 45(2):60-2. PubMed ID: 8772396
[TBL] [Abstract][Full Text] [Related]
12. Metabolic and secretory response to D-fructose in pancreatic islets from adult rats injected with streptozotocin during the neonatal period.
Scruel O; Giroix MH; Sener A; Portha B; Malaisse WJ
Mol Genet Metab; 1999 Sep; 68(1):86-90. PubMed ID: 10479486
[TBL] [Abstract][Full Text] [Related]
13. [Suitability of specific staining methods for the estimation of beta cell volume in rat pancreas with normal and reduced insulin content].
Lucke VS; Ziegler B; Diaz-Alonso JM; Hahn HJ
Acta Histochem; 1985; 77(1):107-16. PubMed ID: 2414957
[TBL] [Abstract][Full Text] [Related]
14. The optimum dose of nicotinamide for protection of pancreatic beta-cells against the cytotoxic effect of streptozotocin in albino rat.
Hassan N; Janjua MZ
J Ayub Med Coll Abbottabad; 2001; 13(3):26-30. PubMed ID: 11873395
[TBL] [Abstract][Full Text] [Related]
15. DNA synthesis in pancreatic islet and acinar cells in rats with streptozotocin-induced diabetes.
Hamming NA; Reynolds WA
Horm Metab Res; 1977 Mar; 9(2):114-6. PubMed ID: 140841
[TBL] [Abstract][Full Text] [Related]
16. Glucose and ATP levels in pancreatic islet tissue of normal and diabetic rats.
Matschinsky FM; Pagliara AS; Stillings SN; Hover BA
J Clin Invest; 1976 Nov; 58(5):1193-200. PubMed ID: 136453
[TBL] [Abstract][Full Text] [Related]
17. Effect of cerebrocrast, a new long-acting compound on blood glucose and insulin levels in rats when administered before and after STZ-induced diabetes mellitus.
Briede J; Stivrina M; Stoldere Dz; Vigante B; Duburs G
Cell Biochem Funct; 2007; 25(6):673-80. PubMed ID: 16986170
[TBL] [Abstract][Full Text] [Related]
18. Survival of islet isografts despite cytotoxicity against pancreatic islets measured in vitro.
Ziegler B; Köhler E; Klöting I; Besch W; Ziegler M
Exp Clin Endocrinol; 1990 Feb; 95(1):31-8. PubMed ID: 2139850
[TBL] [Abstract][Full Text] [Related]
19. Recovery in the fetal pancreatic islet following fetal administration of streptozotocin in the rat in vivo and in vitro.
Yamamoto M; Yasuda M; Hori A; Arishima K; Eguchi Y
Anat Rec A Discov Mol Cell Evol Biol; 2004 Dec; 281(2):1319-25. PubMed ID: 15515161
[TBL] [Abstract][Full Text] [Related]
20. Streptozotocin-induced suppression of FAD-linked glycerophosphate dehydrogenase in pancreatic islets of adult rats.
Rasschaert J; Malaisse WJ
Biochem Int; 1991 Mar; 23(4):707-14. PubMed ID: 1831360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
